Iaso Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Sea PharmaceuticalsJul 2025SEC filingmedium confidence
BiotechCambridge, US
James P. Pearson(PRESIDENT, CHIEF EXECUTIVE OFFICER, CHIEF SCIENCE OFFICER)Michael Higgins(Manager)Eric Olson(Manager)W. Kendall Brown(Manager)Benjamin Cravatt(Manager)Eduardo J. Martinez(Vice President)
Board seatMark G. Currie· per SEC Form D · $1.7M raise · filed May 2026
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.